NASDAQ | ETF
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index.
The index includes common stocks and depositary receipts ofU. S. exchange-listed companies in the pharmaceutical industry.
Such companies may include medium-capitalization companies and foreign companies that are listed on aU. S. exchange.
It is non-diversified.
Top 20 Holdings
Asset | Name | Sector | Industry | Weight |
---|---|---|---|---|
LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 12.84% |
JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 6.88% |
ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 5.90% |
NVS | Novartis AG ADR | Healthcare | Drug Manufacturers - General | 5.57% |
COR | Cencora Inc. | Healthcare | Medical Distribution | 5.46% |
MCK | McKesson Corporation | Healthcare | Medical Distribution | 5.25% |
TAK | Takeda Pharmaceutical Co Ltd ADR | Healthcare | Drug Manufacturers - Specialty & Generic | 4.93% |
H6D | Haleon PLC | 4.93% | ||
AZN | AstraZeneca PLC ADR | Healthcare | Drug Manufacturers - General | 4.85% |
SNY | Sanofi ADR | Healthcare | Drug Manufacturers - General | 4.84% |
GSK | GlaxoSmithKline PLC ADR | Healthcare | Drug Manufacturers - General | 4.62% |
MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 4.57% |
ZTS | Zoetis Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 4.48% |
ABC | AmerisourceBergen | Healthcare | Medical Distribution | 4.39% |
NVO | Novo Nordisk A/S | Healthcare | Drug Manufacturers - General | 4.27% |
PFE | Pfizer Inc | Healthcare | Drug Manufacturers - General | 4.23% |
BMY | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 4.03% |
TEVA | Teva Pharma Industries Ltd ADR | Healthcare | Drug Manufacturers - Specialty & Generic | 3.98% |
VTRS | Viatris Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 2.19% |
JAZZ | Jazz Pharmaceuticals PLC | Healthcare | Biotechnology | 1.69% |